Ananthakrishnan et al listed risk factors for a severe outcome in a patient with inflammatory bowel disease who becomes infected with Clostridium difficile. These can help to identify a patient who may benefit from more aggressive management. The authors are from Massachusetts General Hospital and Harvard Medical School.